GlaxoSmithKline Pharmaceuticals Receives TDS Demand Order
GlaxoSmithKline Pharmaceuticals Limited has received a Final Order from the TDS Authority, INT Tax Circle 2(3)(2), imposing a TDS Demand Liability of Rs 2.01 Crores. The order, dated March 31, 2026, relates to a default under Section 201 for the assessment year 2020-2021.The TDS demand includes Rs 1.11 Crores in TDS and Rs 0.90 Crores in interest.According to a filing, the company is contesting the assessment order and intends to file an appeal before the appellate authority. Management stated that the order is not expected to have an impact on the company’s financial statements.ParticularsDetailsAuthorityTDS Authority - INT Tax Circle 2(3)(2)Nature of ActionDemand...